4DMedical (ASX:4DX) secured a commercial contract with Utah-based Intermountain Health to implement its pulmonary hypertension analysis product, according to a Monday filing with the Australian bourse.
The pulmonary hypertension analysis product is an artificial-intelligence-based algorithm designed for acute care settings to aid response teams in assessing pulmonary hypertension due to pulmonary embolism, the filing said.
The contract was secured through Microsoft-owned Nuance Communications as part of the company's strategic distribution partnership, according to the filing.
4DMedical shares were up 5% in morning trade on Monday.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.